BioCentury
ARTICLE | Company News

Lexicon to acquire Coelacanth

June 13, 2001 7:00 AM UTC

LEXG will acquire Coelacanth (Princeton, N.J.) for $32 million in stock. The merger combines LEXG's knockout mouse functional genomics platform with Coelacanth's chemistry technology for NCE identific...